尼奥金公司

最新新闻

• 评级变动
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 公司公告
  Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.
  SEC · 2026/1/29
• 评级变动
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/1/9
• Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
  TipRanks · 2026/9/28
• 评级变动
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/8/4
• 公司公告
  Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.
  SEC · 2026/1/26
• Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
  TipRanks · 2026/7/30
• 评级变动
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• 公司公告
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
  SEC · 2025/12/3
• 评级变动
  CJS Securities Upgrades Neogen(NEOG.US) to Buy Rating, Maintains Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2025/12/10
• 评级变动
  CJS Securities Initiates Neogen(NEOG.US) With Hold Rating, Announces Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2025/9/29
• 公司公告
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
  SEC · 2025/10/29
• 评级变动
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $6.5
  \u5e02\u573a\u8d44\u8baf · 2025/10/16
• William Blair Maintains Neogen(NEOG.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 公司公告
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.
  SEC · 2026/1/26
• 评级变动
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/1/13
• 评级变动
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Cuts Target Price to $8
  \u5e02\u573a\u8d44\u8baf · 2025/10/10

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。